Deauthorized COVID-19 treatments still administered in 2022 - study
Researchers discovered that in early 2022, hospitals administered 158,000 doses of unauthorized monoclonal antibody treatments.
A vial of Regeneron monoclonal antibody sits on a medical table as registered nurse Jessica Krumwiede attempts to find a vein to administer it to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota(photo credit: REUTERS/SHANNON STAPLETON)
